Re: Neuroleptic malignant syndrome associated with quetiapine.
Karagianis
J
J
Phillips
L
L
Hogan
K
K
LeDrew
K
K
D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003987:Dibenzothiazepines / Q000009:adverse effects* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D008152:Loxapine / Q000009:adverse effects / Q000627:therapeutic use; D009459:Neuroleptic Malignant Syndrome / Q000209:etiology*; D000069348:Quetiapine Fumarate; D012307:Risk Factors
D014150:Antipsychotic Agents; D003987:Dibenzothiazepines; D000069348:Quetiapine Fumarate; D008152:Loxapine